Kurs & Likviditet
+4,00%
|
7,75 MNOK
Kursutveckling och likviditet under dagen för detta pressmeddelande
Kalender
2024-11-06 | Kvartalsrapport 2024-Q3 |
2024-08-22 | Kvartalsrapport 2024-Q2 |
2024-06-06 | Ordinarie utdelning AZT 0.00 NOK |
2024-06-05 | Årsstämma 2024 |
2024-05-08 | Kvartalsrapport 2024-Q1 |
2024-02-01 | Bokslutskommuniké 2023 |
2023-11-02 | Kvartalsrapport 2023-Q3 |
2023-08-17 | Kvartalsrapport 2023-Q2 |
2023-06-07 | Ordinarie utdelning AZT 0.00 NOK |
2023-06-06 | Årsstämma 2023 |
2023-05-04 | Kvartalsrapport 2023-Q1 |
2023-02-02 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-08-18 | Kvartalsrapport 2022-Q2 |
2022-06-23 | Årsstämma 2022 |
2022-05-27 | Ordinarie utdelning AZT 0.00 NOK |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-01-27 | Bokslutskommuniké 2021 |
2021-10-28 | Kvartalsrapport 2021-Q3 |
2021-08-19 | Kvartalsrapport 2021-Q2 |
2021-05-21 | Ordinarie utdelning AZT 0.00 NOK |
2021-05-20 | Årsstämma 2021 |
2021-04-22 | Kvartalsrapport 2021-Q1 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-10-22 | Kvartalsrapport 2020-Q3 |
2020-08-19 | Kvartalsrapport 2020-Q2 |
2020-05-15 | Ordinarie utdelning AZT 0.00 NOK |
2020-05-14 | Årsstämma 2020 |
2020-04-23 | Kvartalsrapport 2020-Q1 |
2020-01-30 | Bokslutskommuniké 2019 |
2020-01-06 | Extra Bolagsstämma 2020 |
2019-10-24 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-05-16 | Ordinarie utdelning AZT 0.00 NOK |
2019-05-15 | Årsstämma 2019 |
2019-04-30 | Kvartalsrapport 2019-Q1 |
2019-01-30 | Bokslutskommuniké 2018 |
2018-10-18 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-09 | Ordinarie utdelning AZT 0.00 NOK |
2018-05-07 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-02-01 | Bokslutskommuniké 2017 |
2017-10-19 | Kvartalsrapport 2017-Q3 |
2017-08-17 | Kvartalsrapport 2017-Q2 |
2017-05-12 | Ordinarie utdelning AZT 0.00 NOK |
2017-05-11 | Årsstämma 2017 |
2017-04-27 | Kvartalsrapport 2017-Q1 |
2017-02-02 | Bokslutskommuniké 2016 |
2016-10-26 | Kvartalsrapport 2016-Q3 |
2016-08-17 | Kvartalsrapport 2016-Q2 |
2016-05-12 | Ordinarie utdelning AZT 0.00 NOK |
2016-05-11 | Årsstämma 2016 |
2016-04-19 | Kvartalsrapport 2016-Q1 |
2016-02-11 | Bokslutskommuniké 2015 |
2016-02-11 | Kapitalmarknadsdag 2016 |
2015-11-03 | Kvartalsrapport 2015-Q3 |
2015-08-13 | Kvartalsrapport 2015-Q2 |
2015-05-13 | Ordinarie utdelning AZT 0.00 NOK |
2015-05-12 | Årsstämma 2015 |
2015-05-05 | Kvartalsrapport 2015-Q1 |
2015-02-17 | Bokslutskommuniké 2014 |
2014-11-05 | Kvartalsrapport 2014-Q3 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-05-15 | Ordinarie utdelning AZT 0.00 NOK |
2014-05-14 | Årsstämma 2014 |
2014-04-30 | Kvartalsrapport 2014-Q1 |
2014-02-14 | Bokslutskommuniké 2013 |
2013-11-01 | Kvartalsrapport 2013-Q3 |
2013-08-09 | Kvartalsrapport 2013-Q2 |
2013-06-13 | Kapitalmarknadsdag 2013 |
2013-05-28 | Ordinarie utdelning |
2013-05-27 | Årsstämma 2013 |
2013-05-07 | Kvartalsrapport 2013-Q1 |
2013-02-01 | Extra Bolagsstämma 2013 |
2013-01-07 | Bokslutskommuniké 2012 |
2012-11-06 | Kvartalsrapport 2012-Q3 |
2012-08-10 | Kvartalsrapport 2012-Q2 |
2012-05-07 | Ordinarie utdelning AZT 0.00 NOK |
2012-05-07 | Årsstämma 2012 |
2012-05-07 | Kvartalsrapport 2012-Q1 |
2012-02-21 | Bokslutskommuniké 2011 |
2011-11-08 | Kvartalsrapport 2011-Q3 |
2011-08-10 | Kvartalsrapport 2011-Q2 |
2011-05-13 | Kvartalsrapport 2011-Q1 |
2011-05-13 | Årsstämma 2011 |
2011-05-12 | Ordinarie utdelning |
2011-02-17 | Bokslutskommuniké 2010 |
2010-11-12 | Kvartalsrapport 2010-Q3 |
2010-08-10 | Kvartalsrapport 2010-Q2 |
2010-05-11 | Kvartalsrapport 2010-Q1 |
2010-05-04 | Årsstämma 2010 |
2010-03-03 | Bokslutskommuniké 2009 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-12-19 21:34:50
Tromsø, Norway, 19[th] December 2021 - The Board of Directors in ArcticZymes
Technologies ASA (the "Company") has decided to grant 500,000 share options to 4
members of the Company's senior management under the Company's long-term
incentive plan, which was approved by the Annual General Meeting on 20 May 2021.
The strike price of the options are NOK 89.52 - which is equal to the volume
weighted average price for the Company's shares on the Oslo Stock Exchange in
the 30 days' period prior to the grant date. The options will have a 12 months
waiting period, a 36 months vesting period and 12 months exercise period.
The options are granted in accordance with the Company's guidelines for
remuneration to senior management approved by the Annual General Meeting on 20
May 2021.
The following primary insiders were granted options:
Jethro Holter, CEO, was granted 170,000 options, following which he holds in
total 170,000 options and 80,564 shares (after registration and selling of
shares published on the stock exchange 10[ ]December 2021).
Børge Sørvoll, CFO, was granted 130,000 options, following which he holds in
total 330,000 options and 25,428 shares.
Olav Lanes, VP R&D and applications, was granted 100,000 options, following
which he holds 100,000 options and 2,000 shares.
Marit Sjo Lorentzen, Director of Operations, was granted 100,000 options,
following which she holds 115,000 options and 20,331 shares.
For more information, please contact:
Børge Sørvoll
CFO
+47 95290187
ir@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the
development, manufacturing and commercialization of novel recombinant enzymes
for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.
Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec]
ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies
in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at
the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large
portfolio of patents.
For more information, please visit the website: www.arcticzymes.com.